Dr Reddys Laboratories share price
You have to be logged in to add this to Watchlist.Dr Reddys Laboratories is trading 0.29% upper at Rs 6,542.00 as compared to its last closing price. Dr Reddys Laboratories has been trading in the price range of 6,575.00 & 6,484.90. Dr Reddys Laboratories has given 12.70% in this year & 2.84% in the last 5 days.
Dr Reddys Laboratories has TTM P/E ratio 18.37 as compared to the sector P/E of 31.71.There are 32 analysts who have initiated coverage on Dr Reddys Laboratories. There are 6 analysts who have given it a strong buy rating & 5 analysts have given it a buy rating. 8 analysts have given the stock a sell rating.
The company posted a net profit of 1,309.80 Crores in its last quarter.
Listed peers of Dr Reddys Laboratories include Cipla (-1.29%), Zydus Lifesciences (-0.08%), Dr Reddys Laboratories (0.29%) etc.
Dr Reddys Laboratories has a 26.65% promoter holding & 73.17% public holding.The Mutual Fund holding in Dr Reddys Laboratories was at 7.72% in 31 Mar 2024. The MF holding has decreased from the last quarter. The FII holding in Dr Reddys Laboratories was at 29.13% in 31 Mar 2024. The FII holding has increased from the last quarter.
Dr Reddys Laboratories share price range
|
| ||||
|
| ||||
Dr Reddys Laboratories share Key Metrics
| Market Cap ( ₹ Cr.) | 1,08,819.70 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Dr Reddys Laboratories Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 07-May-24 | Audited Results & Final Dividend |
| 30-Jan-24 | Quarterly Results |
| 27-Oct-23 | Quarterly Results |
| 26-Jul-23 | Quarterly Results |
| 10-May-23 | Audited Results & Final Dividend |
| 25-Jan-23 | Quarterly Results |
| 28-Oct-22 | Quarterly Results |
| 28-Jul-22 | Quarterly Results |
| 19-May-22 | Audited Results & Final Dividend |
| 28-Jan-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 16-Nov-23 | 16-Oct-23 | POM |
| 27-Jul-23 | 10-May-23 | AGM |
| 29-Jul-22 | 20-May-22 | AGM |
| 29-Mar-22 | 25-Feb-22 | POM |
| 28-Jul-21 | 20-May-21 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 07-May-24 | - | - | 40 |
| 10-May-23 | - | 11-Jul-23 | 40 |
| 19-May-22 | - | 11-Jul-22 | 30 |
| 14-May-21 | - | 09-Jul-21 | 25 |
FAQs about Dr Reddys Laboratories share price
Dr Reddys Laboratories is trading at 6542.00 as on Mon Jul 08 2024 09:59:56. This is 0.29% upper as compared to its previous closing price of 6522.90.
The market capitalization of Dr Reddys Laboratories is 108950.41 Cr as on Mon Jul 08 2024 09:59:56.
The average broker rating on Dr Reddys Laboratories is Hold. The breakup of analyst rating is given below -
- 6 analysts have given a strong buy rating
- 5 analysts have given a buy rating
- 9 analysts have given a hold rating
- 8 analysts have given a sell rating
- 4 analysts have given a strong sell rating
The 52 wk high for Dr Reddys Laboratories is 6543.20 whereas the 52 wk low is 5042.65
Dr Reddys Laboratories can be analyzed on the following key metrics -
- TTM P/E: 18.37
- Sector P/E: 31.71
- Dividend Yield: 0.61%
- D/E ratio: 0.07
Dr Reddys Laboratories reported a net profit of 5577.90 Cr in 2024.
Dr Reddys Laboratories Quick Links
Dr Reddys Laboratories Dividend Dr Reddys Laboratories Bonus Dr Reddys Laboratories News Dr Reddys Laboratories AGM Dr Reddys Laboratories Rights Dr Reddys Laboratories Splits Dr Reddys Laboratories Board Meetings Dr Reddys Laboratories Key Metrics Dr Reddys Laboratories Shareholdings Dr Reddys Laboratories Profit Loss Dr Reddys Laboratories Balance Sheet Dr Reddys Laboratories Cashflow Dr Reddys Laboratories Q1 Results Dr Reddys Laboratories Q2 Results Dr Reddys Laboratories Q3 Results Dr Reddys Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks